TOI ONCOLOGY INSTITUTE INC (THE)

The Oncology Institute to Participate at Upcoming Investor Conferences

The Oncology Institute to Participate at Upcoming Investor Conferences

CERRITOS, Calif., May 31, 2023 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that senior management will participate at the following investor conferences:

2023 Jefferies Healthcare Conference

Date: June 9th, 2023

Fireside Chat: 11:00am Eastern Time

TOI Participant: Daniel Virnich, M.D., MBA, President

Location: New York City, NY

UBS Healthcare Services Conference

Date: June 26th – 28th, 2023

TOI Participant: Brad Hively, Chief Executive Officer

Location: Chatham, MA

Interested investors and other parties may listen to simultaneous webcasts of the presentations by logging onto the Investor Relations section of the Company’s website at . The online replay will be available for a limited time shortly following the call.

About The Oncology Institute, Inc.

Founded in 2007, TOI is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of approximately 1.8 million patients including clinical trials, transfusions, and other services traditionally associated with the most advanced care delivery organizations. With 100+ employed clinicians and more than 700 teammates in over 60 clinic locations and growing, TOI is changing oncology for the better. For more information visit .

Contacts

Media

The Oncology Institute, Inc.

Daniel Virnich, MD

(562) 735-3226 x 81125

Investors

Solebury Strategic Communications



EN
31/05/2023

Underlying

TOIONCOLOGY INSTITUTE INC (THE)

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on ONCOLOGY INSTITUTE INC (THE)

 PRESS RELEASE
Free
TOI ONCOLOGY INSTIT...

The Oncology Institute Reports Second Quarter 2025 Financial Results a...

The Oncology Institute Reports Second Quarter 2025 Financial Results and Reaffirms Full Year 2025 Guidance CERRITOS, Calif., Aug. 13, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, today reported financial results for its three months ended June 30, 2025. Daniel Virnich, CEO of TOI, commented, "We delivered another strong quarter with over 20% year-over-year revenue growth. This was driven by exceptional performance in our pharmacy business, which grew over 40% ...

August 13, 2025 1 EN
 PRESS RELEASE
Free
TOI ONCOLOGY INSTIT...

The Oncology Institute Announces Changes to Board of Directors

The Oncology Institute Announces Changes to Board of Directors Richard Barasch to Retire; Anne McGeorge Brings Extensive Financial Experience to Role as New Chairman CERRITOS, Calif., Aug. 13, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that Richard Barasch will retire from his role as Chairman of the Board, effective August 12, 2025. Anne McGeorge, who currently serves as a Board Member and Chair of the Audit Committee, will succeed Barasch in the role. “We are thrille...

August 13, 2025 1 EN
 PRESS RELEASE
Free
TOI ONCOLOGY INSTIT...

The Oncology Institute Announces Second Quarter 2025 Earnings Release ...

The Oncology Institute Announces Second Quarter 2025 Earnings Release Date and Conference Call CERRITOS, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that the company will release its second quarter 2025 financial results after the market close on Wednesday, August 13, 2025, to be followed by a conference call the same day at 5:00 p.m. (Eastern Time). The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international cal...

July 24, 2025 1 EN
 PRESS RELEASE
Free
TOI ONCOLOGY INSTIT...

The Oncology Institute Names Kristin England as Chief Administrative O...

The Oncology Institute Names Kristin England as Chief Administrative Officer CERRITOS, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI”), one of the largest value-based oncology groups in the United States, announced today that Kristin England has joined the organization as Chief Administrative Officer (CAO), effective July 7, 2025. In this newly established role, England will oversee Enterprise Central Business Operations and Technology Strategy and Enablement across TOI’s expanding national footprint. England brings over two decades of leaders...

July 14, 2025 1 EN
 PRESS RELEASE
Free
TOI ONCOLOGY INSTIT...

The Oncology Institute and SilverSummit Healthplan Partner to Provide ...

The Oncology Institute and SilverSummit Healthplan Partner to Provide Oncology Care to Over 80,000 Medicaid Members in Nevada CERRITOS, Calif., June 30, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI”), one of the largest value-based oncology groups in the United States, announced today that effective July 1, it will be the exclusive oncology provider for over 80,000 Medicaid patients associated with SilverSummit Healthplan in Nevada. TOI is known for bringing state-of-the-art cancer care to the communities it serves, and their presence in the Las Vegas market w...

June 30, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch